Oncospace
Oncospace is an AI-powered radiation oncology software provider offering clinical decision support and quality assurance solutions for hospitals, cancer centers, and radiation therapy clinics, acquired by Sun Nuclear (a Mirion company) in April 2025.
- Company typePrivate
- Founded2019
- HeadquartersBaltimore, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Oncospace does
Oncospace is a Baltimore-based medical device and software company, founded in 2019, that developed AI-powered radiation oncology software for clinical decision support, treatment planning analytics, and quality assurance. Its technology targets a narrow vertical: hospitals, cancer centers, and radiation oncology clinics seeking to improve radiotherapy treatment planning accuracy, QA workflows, and patient safety. The company's core product is an AI-focused quality enablement platform purpose-built for radiation oncology workflows, distinguishing it from generic AI vendors by its domain specialization.
Pre-acquisition, Oncospace operated as a small private company with 11-50 employees, pursuing a vertical go-to-market into radiation oncology providers. Revenue model, pricing, and detailed customer counts are not publicly disclosed. The company was funded primarily through non-dilutive grants from the National Science Foundation — approximately $1.258 million across 2019 ($225K), 2020 ($25K), and 2021 ($1.008M) — rather than traditional venture capital, indicating a research-and-development-heavy capital structure in its early years.
On April 30, 2025, Oncospace was acquired by Sun Nuclear Corporation, a Mirion Technologies company, integrating its AI capabilities into Sun Nuclear's established radiation oncology QA portfolio alongside products such as SunCHECK, Daily QA 4 Pro, and Plan AI. Following the acquisition, Oncospace operates as a brand within Sun Nuclear's ecosystem, with marketing and global distribution handled through Sun Nuclear's existing sales, training, and support channels rather than independently.
Oncospace firmographics
Firmographics- Name
- Oncospace
- Website
- https://oncospace.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Oncospace is an AI-powered radiation oncology software provider offering clinical decision support and quality assurance solutions for hospitals, cancer centers, and radiation therapy clinics, acquired by Sun Nuclear (a Mirion company) in April 2025.
- Ownership category
- akta.pro rank
Oncospace industry classification
Industry- Product category
- Radiation Oncology Software
- NAICS
- Irradiation Apparatus Manufacturing (334517), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industry
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
Keywords
Where Oncospace is headquartered
LocationHeadquarters
- HQ city
- Baltimore
- HQ country
- United States
- HQ region
- North America
Markets served
Oncospace business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Oncospace product offering
Product offeringCore offering
Oncospace develops AI-focused radiation oncology software that provides clinical decision support and data analytics for radiation therapy treatment planning and quality assurance. The software is designed to enhance treatment planning accuracy and patient safety optimization for hospitals, cancer centers, and radiation oncology clinics. Following Sun Nuclear's April 2025 acquisition, Oncospace's capabilities are integrated into Sun Nuclear's radiation oncology quality management portfolio.
Product overview
Oncospace is an AI-focused radiation oncology software provider acquired by Sun Nuclear in April 2025. Following the acquisition, Oncospace operates as a brand within Sun Nuclear's radiation therapy quality management ecosystem, complementing Sun Nuclear's existing portfolio of QA products including SunCHECK, Daily QA, and Plan AI. The specific product offerings, modules, and technical capabilities of Oncospace's software platform are not detailed in the available source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Oncospace AI Radiation Oncology Software
Companies that use Oncospace
Customer profileSegments1 record
Ideal customer profiles1 record
Oncospace technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Oncospace partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sun NuclearcoreSun Nuclear, a Mirion Technologies company, acquired Oncospace on April 30, 2025. Oncospace is an AI-focused radiation oncology software provider. The acquisition integrates Oncospace's AI capabilities into Sun Nuclear's radiation oncology quality management solutions portfolio, enhancing patient safety offerings.
Recent moves5 records
Expansion highlights4 records
Oncospace competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights5 records
Customer concentration
Oncospace financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oncospace leadership team
Management profileNumber of profiles
Profiles2 records
Oncospace funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oncospace M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oncospace
What does Oncospace do?
Oncospace develops AI-focused radiation oncology software that provides clinical decision support and data analytics for radiation therapy treatment planning and quality assurance. The software is designed to enhance treatment planning accuracy and patient safety optimization for hospitals, cancer centers, and radiation oncology clinics. Following Sun Nuclear's April 2025 acquisition, Oncospace's capabilities are integrated into Sun Nuclear's radiation oncology quality management portfolio.
Is Oncospace a public or private company?
Oncospace is a private company. It is classified as corporate owned and is currently acquired.
When was Oncospace founded?
Oncospace was founded in 2019. It employs 11 to 50 people.
Where is Oncospace based?
Oncospace is headquartered in Baltimore, United States, in the North America region.
Does Oncospace have an API?
No public API is recorded for Oncospace.
What industry is Oncospace in?
Oncospace's product category is Radiation Oncology Software. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 7372.